Related Experiment Video
Updated: Aug 17, 2026

Detection of Bacteria Using Fluorogenic DNAzymes
Published on: May 28, 2012
Deoxyribozymes: cleaving a path to clinical trials
1GeneType Research Laboratories, 60 Hanover Street, Fitzroy 3065, Victoria, Australia. crispin.dass@genetype.com.au
Abstract:
Deoxyribozymes (DNAzymes) comprise an exciting class of nucleic acid molecules that are capable of specific cleavage of target mRNA. Recent reports attest to the potential of this class of molecules in cell culture and preclinical studies, where DNAzymes exhibit the ability to silence disease-associated genes (mainly those associated with cardiovascular disease and cancer). Rigorous testing in preclinical studies is now required before this relatively new entity enters Phase I clinical trials.
Related Concept Videos
Ribozymes
Ribozymes can be...
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Ribozymes
Ribozymes can be...
Drug Discovery: Overview

